Centene (CNC) vs Henry Schein (HSIC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Centene (CNC) has outperformed Henry Schein (HSIC) over the past year, gaining 69.2% versus a gain of 30.7%. Over five years, HSIC leads with a +9.3% price change compared with -0.5% for CNC. Centene is the larger company by market cap ($31.88 billion vs $9.43 billion), about 3.4 times the size.
On valuation, Centene trades at a lower forward P/E (12.1x vs 14.1x for Henry Schein). Henry Schein converts more of its revenue into profit, with a net margin of 3.0% versus -3.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNC | HSIC |
|---|---|---|
| Share price | $64.54 | $84.63 |
| Market cap | $31.88B | $9.43B |
| 1-day change | -0.69% | +1.16% |
| YTD return | +57.93% | +11.97% |
| 1-year return | +69.16% | +30.74% |
| 5-year return | -0.51% | +9.28% |
| P/E ratio (TTM) | — | 24.67 |
| Forward P/E | 12.07 | 14.14 |
| EPS (TTM) | $-10.44 | $3.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $194.78B | $13.18B |
| Revenue growth (YoY) | +19.44% | +4.03% |
| Net income (latest FY) | $-6.67B | $398.00M |
| Gross margin | 7.30% | 31.14% |
| Operating margin | -3.91% | 4.95% |
| Net margin | -3.43% | 3.02% |
| 52-week high | $69.63 | $92.18 |
| 52-week low | $31.63 | $61.95 |
| Distance from 52-week high | -7.31% | -8.19% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +11.22% | +14.94% |
| Average volume | 4.57M | 1.22M |
| Shares outstanding | 494.00M | 111.45M |
| Employees | 61,100 | 25,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Centene is about 3.4 times larger than Henry Schein by market value ($31.88B vs $9.43B).
- CNC has outperformed HSIC by 38.4 percentage points over the past year.
- Henry Schein is more profitable, keeping 3.0 cents of every revenue dollar as net income versus -3.4 cents for Centene.
- Centene grew revenue faster in its latest fiscal year (+19.44% vs +4.03%).
About Centene
CNC stock →Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Health Care · Medical Specialities · 61,100 employees
About Henry Schein
HSIC stock →Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
Health Care · Medical Specialities · 25,000 employees
CNC vs HSIC FAQ
Which is bigger, Centene or Henry Schein?
Centene (CNC) is larger, with a market capitalization of $31.88B compared with $9.43B for Henry Schein (HSIC).
Which stock has performed better over the past year, CNC or HSIC?
CNC returned +69.16% over the past 12 months, compared with +30.74% for HSIC (price return, excluding dividends). Past performance does not predict future results.
Are Centene and Henry Schein in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.